KREBSBIO.NSE Krebs Biochemicals & Industries Ltd.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Krebs Biochemicals & Industries Ltd. market cap is 1.42B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Krebs Biochemicals & Industries Ltd. 52 week high is 93.95 as of May 13, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Krebs Biochemicals & Industries Ltd. 52 week low is 59.20 as of May 13, 2024.

Krebs Biochemicals & Industries Ltd. stock price today is 67.45.

Krebs Biochemicals & Industries Ltd. stock price yesterday was 65.50.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Krebs Biochemicals & Industries Ltd.’s P/E ratio is -6.81.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Krebs Biochemicals & Industries Ltd. P/B ratio is -1.3082.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Krebs Biochemicals & Industries Ltd.'s EBITDA is -32.58.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Krebs Biochemicals & Industries Ltd. 50-day moving average is 69.29.

Krebs Biochemicals & Industries Ltd. has 210 employees.